Mucoepidermoid carcinoma epidemiology and demographics

Jump to: navigation, search

Mucoepidermoid carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucoepidermoid Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucoepidermoid carcinoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mucoepidermoid carcinoma epidemiology and demographics

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucoepidermoid carcinoma epidemiology and demographics

CDC on Mucoepidermoid carcinoma epidemiology and demographics

Mucoepidermoid carcinoma epidemiology and demographics in the news

Blogs on Mucoepidermoid carcinoma epidemiology and demographics

Directions to Hospitals Treating Mucoepidermoid carcinoma

Risk calculators and risk factors for Mucoepidermoid carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] , Maria Fernanda Villarreal, M.D. [3]

Overview

Mucoepidermoid carcinoma is the most common malignant salivary gland tumor among general population. The incidence of mucoepidermoid carcinoma is approximately 2.5 to 3.0 cases per 100,000 individuals a year. The incidence of mucoepidermoid carcinoma increases with age. The median age at diagnosis is between 20 to 50 years. Females are slightly more affected with mucoepidermoid carcinoma than males. There is no racial predilection for mucoepidermoid carcinoma.

Epidemiology and Demographics

Incidence

  • The overall adjusted incidence rate of mucoepidermoid carcinoma is approximately 2.5 to 3.0 cases per 100,000 individuals a year.[1]

Prevalence

Age

  • The median age at diagnosis is between 20 to 60 years.[2][2]

Gender

  • Females are slightly more affected with mucoepidermoid carcinoma than males.[3]
  • The male to female ratio is approximately 3:2.[4]
  • In mucoepidermoid carcinoma, males are more commonly affected by the aggressive tumor form than females.

Race

  • There is no racial predilection for mucoepidermoid carcinoma.[2][5]

References

  1. Mucoepidermoid carcinoma. Radiopedia. Dr Frank Gailliard. http://radiopaedia.org/articles/mucoepidermoid-carcinoma-of-salivary-glands Accessed on February 17, 2016
  2. 2.0 2.1 2.2 2.3 Eneroth, C.-M. (1971), Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer, 27: 1415–1418. doi: 10.1002/1097-0142(197106)27:6<1415::AID-CNCR2820270622>3.0.CO;2-X
  3. Devaraju R, Gantala R, Aitha H, Gotoor SG (August 2014). "Mucoepidermoid carcinoma". BMJ Case Rep. 2014: bcr–2013–202776. doi:10.1136/bcr-2013-202776. PMC 4127757. PMID 25085946.
  4. Maloth AK, Nandan SR, Kulkarni PG, Dorankula SP, Muddana K (December 2015). "Mucoepidermoid Carcinoma of Floor of the Mouth - A Rarity". J Clin Diagn Res. 9 (12): ZD03–4. doi:10.7860/JCDR/2015/15595.6912. PMID 26813873.
  5. Evans HL (1984). "Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading". Am. J. Clin. Pathol. 81 (6): 696–701. PMID 6731349.

Linked-in.jpg